MindMaze Therapeutics Holding SA — key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023)

CHF 6.3M

Net Income/Loss (FY2023)

-CHF 98.2M

Total Assets (FY2023)

CHF 76.4M

Total Equity (FY2023)

CHF 52.2M

Cash Flows from Operating Activities (FY2023)

-CHF 17.6M

Source: MindMaze Therapeutics Holding SA 20-F filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.